The 340B drug pricing program has long been a critical tool for community health centers, enabling them to stretch scarce resources and deliver affordable care to millions of patients—often in America’s rural and underserved communities. But today, this key healthcare funding lifeline is facing new challenges that could threaten its future. In our latest episode […]